Lonza buys U.S. clinical manufacturing site from Shire

ZURICH (Reuters) - Lonza Group is acquiring a clinical-stage mammalian manufacturing site in the United States from Shire PLC, the Swiss pharmaceutical ingredients group said on Tuesday without giving the purchase price.